Recombinant glucagon: a differential biological activity

Abstract

In Brazil, there is a growing demand for specialised pharmaceuticals, and the high cost of their importation results in increasing costs, reaching US$ 1.34 billion in 2012 and US$ 1.61 billion in 2013. Worldwide expenses related to drugs could reach US$ 1.3 trillion in 2018, especially due to new treatments for hepatitis C and cancer. Specialised or high-cost pharmaceutical drugs used for the treatment of viral hepatitis, multiple sclerosis, HIV and diabetes are distributed free of charge by the Brazilian government. The glucagon peptide was included in this group of high-cost biopharmaceuticals in 2008. Although its main application is the treatment of hypoglycaemia in diabetic patients, it can also be used with patients in an alcoholic coma, for those patients with biliary tract pain, and as a bronchodilator. Therefore, in order to reduce biopharmaceutical production costs, the Brazilian government passed laws focusing on the development and increase of a National Pharmaceutical Industrial Centre, including the demand for the national production of glucagon. For that reason and given the importance and high cost of recombinant glucagon, the purpose of this study was to develop methods to improve production, purification and performance of the biological activity of recombinant glucagon. Glucagon was recombined into a plasmid vector containing a Glutathione S-transferase tag, and the peptide was expressed in a heterologous Escherichia coli system. After purification procedures and molecular analyses, the biological activity of this recombinant glucagon was examined using in vivo assays and showed a highly significant (p < 0.00001) and prolonged effect on glucose levels when compared with the standard glucagon. The experimental procedure described here facilitates the high level production of recombinant glucagon with an extended biological activity.

Produção e purificação do peptídeo hemopressina visando potencial farmacológico

“…Sendo assim, tal resina foi utilizada para purificação da hemopressina, por cromatografia de afinidade, no fluxo de 1 mL por minuto. Após a adição da proteína total, foram coletadas alíquotas de 1 mL do lavado (tampão de lavagem -PBS) e do eluído (tampão de eluição) e analisadas em gel SDS-PAGE 15% (Figura 5), demonstrando que a purificação ocorreu de forma satisfatória, tendo em vista que o procedimento permitiu a obtenção da molécula com aproximadamente 90% de grau de pureza, o mesmo valor obtido Basso et al (2015), com o uso desta metodologia.…”